Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Steven Madden
SHOO
$3.37B
| $39.4M | 0.05% |
934,980
+861,433
| +1,171% | +$34.9M |
|
427
Clorox
CLX
$12.9B
| $39.3M | 0.05% |
411,686
+247,953
| +151% | +$23.8M |
|
428
Huntington Ingalls Industries
HII
$11.8B
| $39.1M | 0.05% |
139,815
+134,671
| +2,618% | +$45M |
|
429
W.W. Grainger
GWW
$61.8B
| $39.1M | 0.05% |
28,730
+21,888
| +320% | +$27M |
|
430
Granite Construction
GVA
$5.5B
| $38.8M | 0.05% |
245,464
+118,892
| +94% | +$16.2M |
|
431
Cboe Global Markets
CBOE
$31.4B
| $38.8M | 0.05% |
159,694
+150,947
| +1,726% | +$46.2M |
|
432
PUT
Intel
INTC
$476B
| $38.7M | 0.05% |
277,500
-150,600
| -35% | -$15.2M |
|
433
Realty Income
O
$59.2B
| $38.6M | 0.05% |
623,444
+608,914
| +4,191% | +$38M |
|
434
Micron Technology
MU
$1.09T
| $38.5M | 0.05% |
33,356
-6,590
| -16% | -$4.94M |
|
435
Moody's
MCO
$87.2B
| $38.4M | 0.05% |
84,825
+82,335
| +3,307% | +$37M |
|
436
Arrowhead Research
ARWR
$12.3B
| $38.4M | 0.05% |
470,754
+264,342
| +128% | +$19.5M |
|
437
RH
RH
$2.9B
| $38.3M | 0.05% |
232,674
+231,764
| +25,469% | +$31.9M |
|
438
Cintas
CTAS
$81.6B
| $38.2M | 0.05% |
224,334
+213,231
| +1,920% | +$36.9M |
|
439
KB Home
KBH
$3.39B
| $38.1M | 0.05% |
+608,767
| New | +$31.7M |
|
440
CALL
Eli Lilly
LLY
$1.12T
| $37.9M | 0.05% |
31,600
+15,200
| +93% | +$15.5M |
|
441
Allegiant Air
ALGT
$2.24B
| $37.7M | 0.05% |
320,905
+240,378
| +299% | +$20.8M |
|
442
CareTrust REIT
CTRE
$9.35B
| $37.7M | 0.05% |
934,804
+171,978
| +23% | +$6.75M |
|
443
CALL
UnitedHealth
UNH
$350B
| $37.6M | 0.05% |
90,500
-45,700
| -34% | -$16.9M |
|
|
FLG
444
Flagstar Bank National Association
FLG
$5.59B
| $37.3M | 0.05% |
2,495,142
-1,223,420
| -33% | -$17.3M |
|
445
Wells Fargo
WFC
$254B
| $37.1M | 0.05% |
+448,401
| New | +$36M |
|
446
Cogent Biosciences
COGT
$6.37B
| $37M | 0.05% |
954,843
+98,245
| +11% | +$3.44M |
|
447
Crown Holdings
CCK
$13B
| $36.9M | 0.05% |
+329,890
| New | +$33.3M |
|
448
CALL
Citigroup
C
$221B
| $36.7M | 0.05% |
262,500
+143,800
| +121% | +$18.7M |
|
449
Liberty Energy
LBRT
$3.16B
| $36.7M | 0.05% |
1,401,121
+1,079,306
| +335% | +$32.3M |
|
450
PUT
ConocoPhillips
COP
$162B
| $36.7M | 0.05% |
352,900
-137,100
| -28% | -$16.2M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.